Astellas Venture Management, the corporate venturing division of Japan-based pharmaceutical company Astellas, has participated in a £3.8m ($6m) tranched equity financing for Bicycle Therapeutics, a UK-based biotherapeutics startup spun out of the UK Medical Research Council’s Laboratory of Molecular Biology in 2009.  Return backers venture capital firm Atlas Venture, Novartis Venture Fund, the $750m corporate…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.